Cannabinoid Research: Mental Health in Retired Athletes
Mental health retired athletes research reveals elevated rates of depression, anxiety, and cognitive issues after sports careers end. Factors like head trauma and loss of identity contribute significantly. This research underscores the importance of…
Cannabis Compounds May Reverse Fatty Liver Disease, Study Suggests – Science Alert
Emerging research highlights cannabinoid efficacy nonalcoholic fatty liver disease, focusing on CBD and CBG's potential benefits. These cannabinoids may regulate metabolism and reduce lipid accumulation in the liver. However, clinical trials are needed…
Millions Use Marijuana to Cope with Anxiety and Depression, But a Major New Study Says It …
A comprehensive review of cannabis for anxiety and depression reveals insufficient evidence supporting its use for these conditions. Millions use cannabis for symptom relief, but clinical trials show limited efficacy. Potential risks include worsening…
Ethics Committee in the Netherlands Approves Parkinson’s Cannabis Trial
The cannabis-derived therapeutic candidate Parkinson's disease trial has received ethics committee approval in the Netherlands. This milestone advances clinical evidence for cannabinoid treatments in neurodegenerative conditions. Clinicians should…
Medical Cannabis Not Effective as a Mental Health Treatment, Finds Meta Analysis
A recent meta-analysis evaluated medical cannabis mental health efficacy and found insufficient evidence supporting its use for psychiatric disorders. Clinicians should counsel patients on the limited benefits of medical cannabis for anxiety and…
‘No evidence’ of medicinal cannabis effectiveness treating anxiety, depression or PTSD
Current cannabis anxiety depression PTSD evidence does not support medicinal cannabis as an effective treatment for these conditions. Clinicians should be cautious in recommending cannabis until higher-quality research emerges. Patients need accurate…
Why product labels still fail too many patients #5
A blog concept about labeling confusion and the real-world consequences for patients.
Understanding Certificates of Analysis: How Patients Can Read Between the Lines
The certificate of analysis cannabis safety is essential for patients to understand product quality and risks. This document verifies cannabinoid profiles and contaminant levels. Patients should always check batch numbers and testing dates to ensure…
DEA Scheduling Synthetic Opioids 2026 Regulatory Updates
This update covers DEA scheduling synthetic opioids 2026 regulatory actions affecting controlled substances. These changes influence clinical practices involving controlled drugs. Cannabis medicine remains primarily governed by state laws and federal…
Cannabinoid Clinical Trials: EEG Insomnia Sleep RCT
This pilot trial studied acute effects of oral cannabinoids on sleep EEG in 20 adults with insomnia. A single dose of THC and CBD altered sleep architecture but did not improve total sleep time. These findings highlight important considerations for…